SUMMARY Rabbit brain endo-oligopeptidase B inactivates angiotensin I (Asp-Arg
T HE release of renin (EC 3.4.99.19) into the circulation triggers the formation of angiotensin II (All) via conversion of angiotensin I (AI) by angiotensin-converting enzyme (EC 3.4.15.1). All produces vasoconstriction and secretion of mineralocorticoid hormones, which lead to salt and water retention and increased arterial blood pressure by acting directly on arterial and adrenal receptors. 1 Several lines of evidence have suggested the presence of the renin-angiotensin system and All in the central nervous system. The effects elicited by central application of All are synergistic with those obtained by systemic injection of this hormone. 8 -' Although several hydrolytic enzymes are capable of terminating the effect of AI and All, little detailed in-formation is available about those that are responsible for the physiological inactivation of these hormones in brain and peripheral tissues. Previous reports from this laboratory described the isolation of endopeptidases A and B from rabbit brain using the peptide hormone bradykinin (Arg-Pro-Pro-Gly-Phe-Ser-ProPhe-Arg) for the detection of peptidase activity. 4 ' 5 Endopeptidase A and B hydrolyze bradykinin at the Phe'-Ser* and Pro'-Phe* peptide bond, respectively. These enzymes were designated endo-oligopeptidases because they hydrolyze internal peptide bonds of oligopeptides but not of oligopeptides attached to soluble polymers. 6 Endo-oligopeptidase B also inactivates luliberin and is inhibited by the nonapeptide BPP M (SQ 20,881, <Gln-Trp-Pro-Arg-Pro-Gln-IlePro-Pro). 7 BPP,,, some related peptides, and amino acid derivatives are potent inhibitors of angiotensinconverting enzyme that have been used to show the participation of the renin-angiotensin system in blood pressure regulation. 8 "
11
The present study demonstrates that rabbit brain endo-oligopeptidase B inactivates both AI and II by hydrolysis of the Pro'-Phe* peptide bond and that this angiotensinase activity is inhibited by BPP, a , a peptide that has been used as a specific inhibitor of angiotensin converting enzyme. Methods AI, All, and related peptides were synthesized by the solid phase method and purified by countercurrent distribution and ion exchange chromatography by Professors A. Paiva and L. Juliano, Escola Paulista de Medicina, Sao Paulo, Brazil. Peptides 13 were homogeneous by the criterion of amino acid composition and by high voltage electrophoresis at pH 2.8, 5.0 and 9.9. BPP M (SQ 20,475), <Gln-Lys-Trp-AlaPro, 1 ' and BPP M (SQ 20,881), <Gln-Trp-Pro-ArgPro-Gln-Ile-Pro-Pro, u were purchased from Schwarz/Mann, Orangeburg, New York. SQ 14,225 D-3-mercapto-2-methylpropanoyl-L-proline (captopril), 18 was provided by Drs. M. Ondetti and D. Cushman of the Squibb Research Institute, Princeton, New Jersey. Stock aqueous solutions of each peptide, 0.5 to 2.0 mg/ml, were stored in siliconized tubes at -22°C. The amino acid composition and concentration of each peptide were determined by amino acid analysis"' " after acid hydrolysis in constant boiling HC1 for 22 hours at 110°C.
Trinitrobenzene sulfonic acid (TNBS), dithiothreitol (DTT), and chemicals used for the amino acid analyzer were products of Pierce Chemical Co., Rockford, Illinois. Aminex A-5 resin was purchased from Bio-Rad, Richmond, California. Pyridine, Fluka purum, was distilled over ninhydrin. Fluorescamine was a product of Roche Diagnostics, Nutley, New Jersey. All other chemicals were reagent grade or equivalent. All glassware was siliconized with Siliclad (Cole Partner, Chicago, Illinois).
Rabbit Brain Endopeptidase B
The enzyme was prepared from the supernatant fraction of rabbit brain by step elution chromatography on DEAE-cellulose, gel filtration on Sephadex G-100, and isoelectric focusing as described by Oliveira et al.' with the modifications in DEAEcellulose chromatography described by Martins et al. 7 The specific activity of the enzyme was 0.78 Mmole/min~1«mg protein" 1 for the hydrolysis of 8 X 10" 8 M bradykinin in 0.05 M sodium phosphate buffer, pH 7.5, containing 0.1 M NaCl, 5 X 10" 4 M DTT at 37°C. 7 The enzyme hydrolyzed only the Pro 7 -Phe a bond of bradykinin 7 and gave only one band after polyacrylamide gel electrophoresis at pH 8.9."
Determination of the Site of Hydrolysis of Angiotensin I and II The conditions for hydrolysis are given in the legend to figure 1. Products and unhydrolyzed substrate were isolated by chromatography on Aminex A-5 resin (0.9 X 30 cm), equilibrated and developed at 22 ml/hour, 60°C. The resin was equilibrated with pyridine-acetic acid buffer, 0.2 M pyridine, pH 3.5 (16.1 ml pyridine, 235 ml acetic acid and H 2 O to 1 liter). After sample application, the column was developed with equilibrating buffer, pH 3.5 for 1 hour, and then eluted with a linear gradient prepared from 250 ml each of 0.9 M pyridine-acetic acid buffer pH 4.25 (72.0 ml pyridine, 120 ml acetic acid and H S O to 1 liter) and 4.0 M pyridine-acetic acid buffer pH 5.0 (320 ml pyridine, 280 ml acetic acid, and H , 0 to 1 liter). The initial period of equilibrium chromatography was used to separate some of the constituent amino acids of AI. The elution volumes were: Asp, 49 ml; Val, He, Leu, 57 ml; Tyr, 63 ml; Phe, 70 ml; His, 127 ml; Arg, 231 ml. The column effluent was divided into two streams: 45% was collected with a fraction collector (1.6 ml/tube) and the remainder was submitted to alkaline hydrolysis and reaction with TNBS in a flow system utilizing a Technicon autoanalyzer, as described by Delaney.
1 " Sodium sulfite was used to increase the sensitivity of the TNBS reaction. 10 A complete description of the apparatus and analytical system is given by Spadaro.
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Effluent corresponding to TNBS-positive material was pooled and submitted to amino acid analysis after acid hydrolysis and to high voltage electrophoresis on Whatmann 3 mm paper at pH 3.5 at 40 V/cm for 3.5 hours in a Savant apparatus. Ninhydrin (0.5% in acetone) and fluorescamine were used for detection. Then 25 nmoles or more of each peptide or amino acid was applied to permit the detection of contaminating material at levels of a minimum of 5% to 10%, if they had been present.
Measurement of Endo-Oligopeptidase B Actirity
All was the substrate for studies of the effect of DTT on enzyme activity and for Km determination. The initial rates of phenylalanine release were determined using the short column (0.9 X 15 cm) of the amino acid analyzer eluted with 0.2 N sodium citrate buffer, pH 3.25, at 58°C.
Both AI and All were substrates used for studies of the time course of hydrolysis and inhibition by BPP,, and related compounds. All the products of the reactions, Phe, [Des-Phe']-AII, and Phe-His-Leu, as well as unhydrolyzed substrates, were determined using an automatic amino acid analyzer." This chromatographic system, capable of detecting 5 to 50 nmoles of amino acids and peptides employs Aminex A-5 resin, sodium citrate buffers, and ninhydrin for detection. Recoveries were calculated by averaging the amount of each product and adding the amount of unhydrolyzed substrate. The incubation conditions are given in the legends to the figures and tables.
Results
Site of Hydrolysis Figure 1 shows the elution diagrams obtained for hydrolysates of AI (top) and All (bottom) by rabbit brain endo-oligopeptidase B. The middle panel is the elution diagram of a mixture of All, His-Leu, and AI. Endo-oligopeptidase B produced only two products from each substrate. The TNBS-positive peak eluted near 115 ml did not contain detectable amino acids either before or after acid hydrolysis. The effluent corresponding to each peak was homogeneous by electrophoresis and amino acid analysis, and the peptides were identified on the basis of amino acid composi- VOL 4 Hydrolysates of AI and All by endo-oligopeptidase B were also characterized analytically using a chromatographic system based on an amino acid analyzer. The data presented in table 2 show that the products were liberated in equimolar amounts during the reaction and that within the experimental error of the method (± 10%) all of the material was accounted for as product or unhydrolyzed substrate. No free amino acids were detected when separate aliquots of the hydrolysates were analyzed by standard amino acid analysis where 1 % of free amino acids would have been readily observed. These data, taken with the information that [Des-Phe*]-AII is biologically inactive," show that brain endopeptidase B acts as an angiotensinase by hydrolyzing the Pro'-Phe" peptide bond of both AI and All.
Dithiothreitol Actiratlon of Endo-Oligopeptidase B
The data in figure 2 show that endo-oligopeptidase B was strongly thiol-dependent. In the absence of DTT, the enzyme activity was only 3% that obtainable with 4.8 mM DTT. With 2 mM DTT, the amount routinely used in assays, 88% of the maximum activity is obtained. The activation by high concentrations of DTT may be due to the reduction of disulfide bridges or to the chelation of metals which inactivate the enzyme.
Km Determination
A Km of 6.3 X 10" 8 M for the hydrolysis of All at pH 8.5, 2.0 mM DTT, 37°C, by endo-oligopeptidase B was calculated from the data presented in figure 3 . Amino acid analyses were performed on 22-hour hydrolysates Theoretical values based on the amino acid sequence of angiotensin I and II are given in parentheses. Amino acids present in concentrations of 0.05 residues/mole or less are not reported (see figure 1) *Electrophoresis was carried out at pH 3 5 and Rf values are relative to arginine. fThe recovery of each peptide was based on the amount of original substrate, uncorrected for chromatographic or manipulative losses.
Inhibition of Endo-Oligopeptidase B by Angiotensin
Converting Enzyme Inhibitors Table 3 shows that 1.8 X lO" M BPP M (SQ 20,881), at a concentration near that of the substrate, inhibited 76% of the angiotensinase activity of the enzyme on AI and 90% of the activity for All. At Angiotensin I (1.9 X 10^ M) and angiotensin II (2.0 X1CH M) were each incubated with endo-oligopeptidase B (2.2 ^g) in 0 5 ml 0.1 M sodium phosphate buffer, pH 8.5, containing 0.06 M NaCl, 2.0 X 10" 3 M DTT at 37°C. The reaction was stopped by the addition of 0.5 ml of 0.2 M sodium citrate buffer, pH 2.2, containing 15% polyethylene glycol. Products and unhydrolyzed substrate, reported as nanomole/ 0 5 ml reaction mixture, were measured simultaneously with an amino acid analyzer. 22 The specific activity of the enzyme was 1.00 ^mole/min^-mg protein" 1 and 0.76 n-J-mg protein" 1 for AI and II, respectively. concentrations of 4.2 X 10" 8 M, BPP to completely inhibited endo-oligopeptidase B. The I M value for the inhibition of endo-oligopeptidase B by BPP,» was approximately 5 X 10"' M. BPPg, was a weaker inhibitor of endo-oligopeptidase B but at high concentra- tions, 4.2 X 10" 3 M, approximately 70% of the activity could be inhibited. Captopril appeared to activate the enzyme slightly at 1.8 X 10"* M. This probably was due to thiol activation of the enzyme by this compound. At high concentrations, 4.2 X 10"* M, captopril inhibited the hydrolysis of AI by 30% but not that of All. The enzyme was incubated with each compound in 0.1 M sodium phosphate buffer, pH 8.5 containing 0 06 M NaCl and 2.0 mM DTT for 10 minutes at 37°C and then with substrate for 30 minutes. Assay conditions: enzyme, 2.2 /ig/ml; substrate, 2 X 10"" 4 M; inhibitor concentrations are given in the table. The reaction was stopped by acidification. Unhydrolyzed substrate and products were measured simultaneously with an amino acid analyzer.
22 ND = not determined.
Discussion
Rabbit brain endo-oligopeptidase B hydrolyzes the Pro-Phe peptide bond in bradykinin and in a series of analogs and fragments.' In this paper we show that the enzyme also acts as an angiotensinase for the precursor peptide AI as well as for All, is thiol-activated, and hydrolyzes All with a Km of 6 X 10"' M. In preparative and analytical experiments, all of the products of hydrolysis of AI and All plus unhydrolyzed substrate were accounted for quantitatively, indicating that hydrolysis occurred only at the Pro-Phe peptide bond. Endo-oligopeptidase B hydrolyzes All I as well as analogs of AI and II when Tyr, Leu, He, or Val occupy the position of Phe in the scissile bond."
The peptides <Gln-Trp-Pro-Arg-Pro-Gln-Ile-ProPro (BPP W , SQ 20,881) and <Gln-Lys-Trp-Ala-Pro (BPPsa, SQ 20,475), isolated from Bothrops jararaca venom,"• u potentiate the action of bradykinin and inhibit the conversion of AI to II in vivo and in vitro and have been used to demonstrate the participation of the renin-angiotensin system in some forms of hypertension. SQ 14, 225 ) is a potent, orally active angiotensin-converting enzyme inhibitor which is currently being tested as an antihypertensive drug.
11 The Ki's for BPP 8 «, BPP 8a , and captopril for rabbit lung angiotensin-converting enzyme are 1.0 X 10" 7 M (competitive inhibitor), 6.0 X 10"* M (mixed inhibitor), and 1.7 X 10"* M (competitive inhibitor), respectively. 15 ' ** These substances are potent inhibitors of angiotensin-converting enzyme and have little activity on other enzymes tested. 11 The results presented here indicate that BPP 9a and, to a lesser extent, BPP 5a , inhibit endo-oligopeptidase B which inactivates AI, All, and AIII. The I M , 5 X 10" 8 M, for BPP te inhibition of the hydrolysis of 2 X 10" 4 M All is near the Ki, 3 X 10"* M, (competitive inhibition) determined using bradykinin as the substrate. 7 In contrast, captopril does not appreciably inhibit endo-oligopeptidase B. Although the inhibition of the enzyme by. BPP M is 1 to 2 orders of magnitude weaker thqn that of ACE, these differences may not be significant in in vivo experiments where large doses of inhibitors are routinely used and local concentrations are unknown. Thus, the interpretation of the pharmacological properties of BPPg., at least when injected intracerebroventricularly,™ must be made not only in terms of the inhibition of angiotensin-converting .enzyme but also in terms of the inhibition of brain endo-oligopeptidase B which inactivates several hormones. Comparison of the effects of BPP 9a and captopril in physiological experiments may provide a way to distinguish between the activity of angiotensin-converting enzyme and of endo-oligopeptidase B.
Several types of angiotensinases have been described. The cathepsin-like enzymes prolylcarboxypeptidase™ and cathepsin A* 0 ' 81 also liberate Phe from All and can be easily distinguished from endo-oligopeptidase B by their acidic pH optima, molecular weight, and because they act as carboxypeptidases.
Cathepsin C, dipeptidyl aminopeptidase,* 1 angiotensinase B
M hydrolyze All at sites other than Pro-Phe. Recently, several enzyme preparations capable of hydrolyzing the Pro-X peptide bond have been isolated from nervous tissue of several species: "thyroliberin-deamidating enzyme",* 4 "prolyl endopeptidase"," "proline endopeptidase," 8 * and "postproline cleaving enzyme."* 7 Each of these enzymes has been shown to hydrolyze the Pro-X peptide bond in one or more of the following peptide hormones: bradykinin, AI, All, AIII, luliberin, thyroliberin, and Substance P. They may be closely related to or identical with rabbit brain endo-oligopeptidase B described by us in 1976."
Extracts of peripheral tissue release the same set of peptides from bradykinin as nervous tissue" and hydrolyze fluorogenic substrates having the general structure carbobenzoxy-X-L-prolyl-4-methoxy-j8-naphthylamide," suggesting that endo-oligopeptidase B or similar enzymes are present both in peripheral as well as in nervous tissues. The term "post-proline cleaving enzyme" was first used by Koida and Walter for a lamb kidney enzyme of molecular weight 115,000 which hydrolyzes All and bradykinin. 40 However, Ser-Pro-Phe-Arg is hydrolyzed faster than bradykinin by endo-oligopeptidase B but not hydrolyzed by the lamb kidney enzyme. 41 Although the role of brain endo-oligopeptidase B remains to be established, inactivation by peptide bond hydrolysis provides a mechanism to regulate the biological activity of peptides, which act as hormones or neurotransmitters in nervous and peripheral tissue. In view of the fact that most hormones are small peptides that contain proline 43 and that most tissue peptidases and proteases do not hydrolyze prolyl-peptide bonds, endo-oligopeptidase B may be considered a likely candidate for this regulatory role by virtue of its specificity for proline in the scissile bond and selectivity for "small" peptides. 4 *
